Nov 11th, 2021
Clinical Interest Article
PARTNER 3—Coverage of TCT 2021
Two-year economic outcomes from a randomized trial of TAVR vs. SAVR in patients at low surgical risk.
Nov 11th, 2021
Clinical Interest Article
CHOICE-CLOSURE—Coverage of TCT 2021
A randomized trial of plug-based versus suture-based large-bore vascular closure.
Nov 11th, 2021
Clinical Interest Article
TRISCEND—Coverage of TCT 2021
Six-month outcomes of transfemoral tricuspid valve replacement in patients with tricuspid regurgitation
Nov 11th, 2021
Clinical Interest Article
INTREPID TMVR Early Feasibility—Coverage of TCT 2021
Thirty-day outcomes following transfemoral transseptal transcatheter mitral valve replacement.
Nov 8th, 2021
Clinical Interest Article
SURTAVI—Coverage of TCT 2021
Five-year results from a randomized trial of TAVR vs. SAVR in patients at intermediate surgical risk.
Nov 6th, 2021
Clinical Interest Article
Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure—Additional Coverage of TCT 2021
Primary results of the SWISS-APERO randomized clinical trial.
Nov 3rd, 2021
Clinical Interest Article
Nov 3rd, 2021
Clinical Interest Article
Oct 13th, 2021
Clinical Interest Article
FDA Approves Amulet LAAO Device Based Upon Amulet IDE Trial
The Amulet IDE study randomized 1878 patients to undergo LAAO with the Amulet device or the Watchman device. Amulet was non-inferior to Watchman wit...
May 19th, 2021
Clinical Interest Article
Investigational Device Evaluation of the WATCHMAN FLX™ LAA Closure Technology (PINNACLE FLX) Trial
Building upon the success of the Watchman device, Boston Scientific (Marlborough, MA) conducted a single-arm 400-patient trial of the next generatio...